8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Brain & Nervous System704 citations

Radiats Biol Radioecol 57(1):71-76, 2017

Bioeffects Seen

Authors not listed · 2017

Share:

Insufficient information to determine key finding.

Plain English Summary

Summary written for general audiences

Insufficient information provided. Only a journal citation (Radiats Biol Radioecol 57(1):71-76, 2017) and organism type (review) were supplied without a title, abstract, or study details. The journal title suggests radiation biology content, but the specific study focus and findings cannot be determined from the metadata alone.

Why This Matters

A complete study record requires at minimum a title and abstract to accurately summarize findings and assess relevance to EMF health effects. The journal Radiatsionnaya Biologiya i Radioekologiya (Radiation Biology and Radioecology) publishes peer-reviewed research on radiation effects, but review articles require content examination to characterize their scope and conclusions.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2017). Radiats Biol Radioecol 57(1):71-76, 2017.
Show BibTeX
@article{radiats_biol_radioecol_57171_76_2017_ce3903,
  author = {Unknown},
  title = {Radiats Biol Radioecol 57(1):71-76, 2017},
  year = {2017},
  doi = {10.1038/s41418-021-00814-y},
  
}
DOI: 10.1038/s41418-021-00814-y

Quick Questions About This Study

The study identified five main types: apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death. These programmed death pathways become abnormally activated in neurodegenerative diseases, leading to unwanted loss of brain cells and function.
Brain cancers show the opposite problem - insufficient cell death. When programmed cell death pathways are inactivated, abnormal cells survive when they should die, contributing to tumor development and making cancers more resistant to treatment.
Various forms of cellular stress from intracellular or extracellular sources can activate these pathways, along with inflammatory processes. The study emphasizes that protecting brain cells from unnecessary stress is crucial for preventing disease.
Yes, researchers are developing drugs that can either inhibit or induce programmed cell death depending on the disease. Some agents targeting key cell death proteins have already progressed to clinical trials for brain diseases.
The review found aberrant cell death pathways in amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, and various brain cancers. This suggests cell death disruption is a common mechanism across neurological conditions.